SUPN - Supernus Company Aggregate Debts

Corporate company logo of Supernus Pharmaceuticals, Inc. (SUPN)

A stable staff of neurobiologists ensures that Supernus Pharmaceuticals (SUPN) develops long-term projects. The company's debt level, for which the chart data is sourced from GURU.Markets, has reached 0.04, serving as a critical benchmark for solvency. The firm generates revenue through the supply of specialized drugs to healthcare systems, while the diversification of CNS therapies minimizes patent cliff risks, stabilizing future cash flows.

SUPN: Supernus Company Debts 07/04/2022 - 10/30/2026
Core merchandise of Supernus

This indicator measures total borrowed funds, allowing investors to assess credit risk and the balance between financial stability and expansion rates. By analyzing total borrowing levels, one can understand how Supernus Pharmaceuticals (SUPN) finances patent acquisitions and strategic alliances in neuropharmaceuticals to scale its CNS drug portfolio without placing a critical burden on capital.

Competing companies

BIIB - Company Cumulative Debt|Neurocrine Biosciences - Company Total Debt|Company Aggregate Debts regencellbioscience.com RGC|AXSM - Company Debts|Aggregate Debt Obligations ACAD (ACADIA Pharma)|Xenon Pharmaceuticals Inc (XENE) - Company Debts|Company Cumulative Debt Viking Therapeutics Corp (VKTX)|Company Debts Catalyst Pharmaceuticals|denalitherapeutics.com (DNLI) - Company Total Debt Obligations|Company Total Debt HRMY (Harmony Biosciences Holdings, Inc.)|Company Aggregate Debts Biohaven Ltd (BHVN)|Company Debts Amylyx AMLX|TRVI (Trevi Corp) - Company Aggregate Indebtedness|Praxis Precision Medicines - Company Aggregate Debts|Company Cumulative Debt anavex.com|CeriBell (CBLL) - Company Debts|Prothena Biosciences - Aggregate Debt Obligations|Company Debts Alector Inc.|Company Aggregate Debt ANNX (Annexon Biosciences Inc.)|Company Total Debt OMER (Omeros Corporation)|Company Aggregate Debts neurogene.com (NGNE)|Company Debts AC Immune SA ACIU|Company Total Debt Obligations Voyager Therapeutics Inc (VYGR)|NMRA: Company Total Debt|Aggregate Debt Obligations SCLX (Scilex Holding Company, Inc.)|Tevogen Bio Holdings (TVGN) - Company Debts|Company Aggregate Indebtedness ACOG (Alpha Cognition Inc.)|CGTX (Cognition Therapeutics, Inc.) - Company Aggregate Debts|IKT: Aggregate Debt Obligations|Company Aggregate Debts SAVA|Company Aggregate Debts assertiotx.com (ASRT)|Company Debts Coya Therapeutics COYA|Aggregate Debt Obligations VTGN|OVID - Company Debts|Acumen Pharmaceuticals Inc. (ABOS) - Company Total Debt|CRVO: Company Aggregate Debts|Alterity Therapeutics Limited (ATHE) - Company Aggregate Debts|CLNN (Clene Inc) - Company Aggregate Debts|Company Total Debt PepGen Corp (PEPG)|Company Aggregate Debts JUNS|RLMD - Company Cumulative Debt|Annovis Bio Corp - Company Total Debt|Company Aggregate Debts Grace Therapeutics Inc GRCE|AIFF: Company Total Debt|Klotho Neurosciences Inc - Company Cumulative Indebtedness|NRSN: Company Aggregate Debts|RVPH - Company Total Debt Obligations|MTVA (MetaVia Inc.) - Company Aggregate Debts|Company Total Debt NeurAxis Inc (NRXS)|Company Aggregate Debts HSDT|Company Aggregate Debts passagebio.com (PASG)|Company Debts Neuphoria Therapeutics NEUP|Minerva Neurosciences Inc - Company Debts|ATHA - Company Debts|Company Total Debt Obligations Addex ADXN|alzamend.com (ALZN) - Company Debts|CYCN - Company Total Debt Obligations|Company Total Debt PTIX|Company Aggregate Debts Pasithea|Company Debts Cortigent, Inc. (CRGT)|ATXI: Company Aggregate Indebtedness|Company Debts Brainstorm Cell BCLI|CARA: Company Aggregate Debt|CHRO - Company Debts|ELYM (Eliem Therapeutics) - Company Aggregate Debt|ITCI: Company Aggregate Debts|Company Cumulative Debt Longboard (LBPH)|Company Total Debt MRNS|Company Aggregate Debts nkgenbiotech.com|Company Debts NeuroBo Pharmaceuticals, Inc. (NRBO)|SAGE (Sage Therapeutics Inc.) - Aggregate Debt Obligations|Company Debts Neurotrope SNPX|Trevena Inc (TRVN) - Company Cumulative Debt|VIGL - Company Debts|Company Total Debt Obligations anewmeds.com WENA|CERE (Cerevel Therapeutics, Inc.) - Company Total Debt